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ABSTRACT
Objective: Objective of the study was to evaluate the level of salivary bone-specific alkaline phosphatase (BALP) during the pubertal growth phases 
in Indonesian children.
Methods: The study conducted on 64 boys and 72 girls who were age group of 8-18 years old were randomly selected. Salivary BALP level were 
estimated using enzyme-linked immunosorbent assay commercial kits and pubertal growth phase were assessed using cervical vertebral maturation 
(CVM) method according to Baccetti. Mean salivary BALP was compared based on pubertal growth groups by analysis of variance test.
Results: Test revealed no significant differences between groups with p=0.312. The highest mean of salivary BALP level was found in the prepeak 
pubertal growth phase (CVM Stage 1-2), and the lowest one was detected in the postpeak pubertal growth phase (CVM Stage 5-6).
Conclusion: The using of salivary BALP as a biomarker for pubertal growth prediction is questionable.
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INTRODUCTION
Identification of the growth phase, with particular regard to the onset of 
the pubertal growth phase, has major clinical implications when dealing 
with orthodontic treatment in growing subjects, especially when there 
are skeletal disharmonies [1,2]. In orthodontics, the classic method 
of assessing pubertal growth phase is through observation of skeletal 
maturity with the most common being the radiography-based, hand-
wrist analysis, and cervical vertebral maturation (CVM) methods [3-6]. 
Those methods are mainly morphological and subjective, while new 
possibilities might be offered by biomarkers (biochemical markers) due 
to they represent agents that are involved directly in bone growth and 
remodeling. The use of biomarkers has been proposed very recently as 
a new aid in assessing individual skeletal maturity, with the advantage 
of being related to the physiology of the patient and of avoiding the use 
of radiations. The very scarce data reported to date include molecular 
constituents from the serum, such as insulin-like growth factor 1 or 
from the gingival crevicular fluid (GCF), such as alkaline phosphatase 
(ALP) [7,8].
Traditionally, total serum ALP activity has been used as a biomarker 
for bone formation. The changes in total serum ALP activity roughly 
reflect the changes in serum bone specific ALP (BALP) levels in healthy 
children. However, the same is not necessarily true in other clinical 
groups because of the changes in liver-specific ALP isoforms caused 
by the underlying disease state, or drug treatment, often affects the 
total serum ALP activity. Measurement of BALP in the serum provides 
a more specific assessment of the growth status of bone in normal 
conditions [9]. Several studies have shown that regardless of gender, 
levels of BALP in serum appear to reach peak values during peak 
puberty and decrease markedly in postpeak puberty. It has hence 
been proven that serum BALP levels fluctuate with puberty, but all of 
them have assessed BALP levels in serum and not many studies have 
been carried out in saliva [9-11]. It is only recently that whole saliva 
has gained significant recognition as a biologic sample to detect 
BALP levels [12]. Research has shown that salivary BALP levels when 
assessed in rats reflected similar patterns of change to those evaluated 
in serum under normal, increased or diminished condition of systemic 
bone turnover [13]. Salivary levels of BALP have been measured in 
correlation with orthodontic tooth movement [14]. However, no study 
has correlated salivary BALP levels with growth status of an individual.
Most commonly used laboratory diagnostic procedures involve the 
analyses of the cellular and chemical constituents of blood. Saliva is a 
mirror of the body and reflects normal and disease state and its use 
as a diagnostic fluid has many merits over serum. Whole saliva can 
be collected non-invasively, and by individuals with limited training, 
including the patient. No special equipment is needed for collection of 
the fluid. Valuable for children, since collection of the fluid is associated 
with fewer compliance problems. Further, analysis of saliva may provide 
a cost-effective approach for the screening of large populations [15,16].
With regard to determination whether the salivary BALP represents a 
non-invasive biomarker of the pubertal growth phase, therefore, the 
aim of this study was to evaluate the level of salivary BALP during the 
pubertal growth phases in Indonesian children.
METHODS
Study population and design
This cross-sectional was conducted in the city of Jakarta, Indonesia, on 
136 (64 boys and 72 girls) Indonesian children. A signed of informed 
accent and consent was obtained from the subjects and their parents 
before enrolment into the study, and the protocol was reviewed and 
approved by the Ethical Committee of Faculty of Dentistry, Universitas 
Indonesia. The following enrolment criteria were observed: (1) Age 
between 8 and 18 years, (2) good general health with the absence 
of any nutritional problems, (3) no use of anti-inflammatories or 
antibiotics in the month preceding entry to the study, and (4) good of 
oral hygiene.
© 2017 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
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Saliva collection procedures
The subjects were scheduled for enrolment at their first clinical 
examination; subsequently, during a second visit 7-10 days before 
saliva collection; they underwent a session of professional supra-
gingival and sub-gingival scaling and also received repeated oral 
hygiene instructions.
The subjects received detailed information about the collection 
protocol, such as the timing of sample collection to ovoid circadian 
effect (all samples were collected in the morning at 9), the exclusion of 
tooth brushing prior to sample collection, and the instruction to avoid 
food and fluid ingestion or chewing gum for at least 30 minutes before 
collection, and mouth cleansing with distilled water. Finally, their 
lateral cephalograms were taken and saliva was collected using passive 
drooling method.
Measurement of total protein and BALP
Saliva sample that has been collected was stored in an ice box before 
sending to the biochemistry laboratory, where they were centrifuged to 
separate the precipitates in saliva. The samples were analyzed for total 
protein content and BALP by using Bradford assay kit (Thermo Fisher 
Scientific, USA) and enzyme-linked immunosorbent assay (ELISA) 
Kit (Elabscience, China), respectively, following the manufacturer’s 
instructions.
Total protein was a non-specific measure of the total amount of all 
proteins present in a solution. It is used to examine the changes in 
overall protein secretion in biologic fluids or to look for differences 
in the ratio of specific proteins to total protein that occur in response 
to physiological changes. Measurement of total protein was used to 
normalize concentrations of various salivary proteins in different 
samples since concentrations can vary significantly in response to 
stimulation or alterations of saliva flow [17-20].
Measurement of total protein and BALP was determined using a 
microplate reader (iMarkTM, Microplate Absorbance Reader; Bio-Rad, 
Hercules, California, USA) set to the optical density (OD) 595 nm and 
450 nm, respectively [21]. For BALP, the enzyme-substrate reaction 
was terminated by the addition of a sulfuric acid solution and the color 
turns yellow. The OD value was proportional to the concentration of 
BALP. The concentration of BALP in the samples was calculated by 
comparing the OD of the samples to the standard curve. The minimum 
detectable dose of BALP was 46.875 pg/mL with coefficient of variation 
were <10%. No significant cross-reactivity or interference between 
BALP and analogs was reported.
Appraisal to pubertal growth phase
Pubertal growth spurt was assessed using the CVM method on lateral 
cephalograms according to the definition as described by Baccetti [5]. 
Briefly, these were defined as follows:
•	 Stage	1:	When	 the	 lower	borders	of	 the	second,	 third	and	 fourth	
vertebrae	(C2,	C3	and	C4)	are	flat	and	the	bodies	of	C3	and	C4	are	
trapezoid in shape. CS1 occurs at least 2 years before the pubertal 
growth spurt;
•	 Stage	2:	When	only	the	lower	border	of	C2	is	concave	and	the	bodies	
of C3 and C4 are trapezoid. CS2 occurs 1 year before the growth spurt;
•	 Stage	3:	When	the	lower	borders	of	both	C2	and	C3	have	concavities	
and the bodies of C3 and C4 are either trapezoid or rectangular 
horizontal in shape. CS3 marks the ascending portion of the growth 
spurt;
•	 Stage	4:	When	the	lower	borders	of	C2-C4	have	concavities,	and	the	
bodies of both C3 and C4 are rectangular horizontal. CS4 marks the 
descending portion of the growth spurt;
•	 Stage	5:	When	the	lower	borders	of	C2-C4	have	concavities	and	at	
least one of the bodies of C3 and C4 is square. CS5 occurs 1 year after 
the growth spurt;
•	 Stage	6:	When	the	lower	borders	of	C2-C4	have	concavities	and	at	
least one of the bodies of C3 and C4 is rectangular vertical. CS6 occurs 
at least 2 years after the growth spurt.
The CVM observer was blinded of the result of biochemical assay of the 
subjects. After the stage of CVM was assessed, then the subjects were 
divided into 3 clusters by pubertal growth phase, i.e.: Prepeak (before 
the pubertal growth spurt; Stage 1 and 2), peak (during the pubertal 
growth spurt; Stage 3 and 4), and post-peak (after the pubertal growth 
spurt; Stage 5 and 6) groups [5]. Salivary BALP levels were then 
subsequently compared according to the pubertal growth phase.
Statistical analysis
Descriptive statistics were used to summarize the distribution of all 
measurements. The intraexaminer agreement of the CVM categories 
was tested with Kappa statistic. The balancing of the groups (pubertal 
growth phases) by sex was tested by Chi-square analysis. An analysis 
of variance and post hoc Tukey honest significant difference test were 
used to compare salivary BALP levels with pubertal growth phase. 
A p<0.05 was used for rejection of the null hypothesis. The data were 
analyzed using SPSS software version 17.0 (SPSS Inc., Chicago, IL, USA).
RESULTS
The distribution of age and salivary BALP as the mean±standard 
deviation were 13.53 years ± 2.72 and 825.90 pg/ml ± 530.99, 
respectively. Kappa statistic for the intraexaminer agreement of the 
CVM appraisal showed a value of above 0.90. The distribution of gender 
was similar among the groups compared (p=0.143). The age of the 
subjects clustered according to the CVM stage and pubertal growth 
phases were shown in Tables 1 and 2.
The level of salivary BALP according to the growth phase can be 
seen in Table 3. We found that the mean level of BALP decreased 
Table 1: Age of the subjects in the different groups according to 
CVM stages
CVM stages n Age (year)
Mean±SD 95% CI
1 20 10.55±0.98 10.09-11.02
2 22 11.16±1.20 10.62-11.69
3 14 12.10±1.65 11.15-13.06
4 37 13.91±2.23 13.16-14.66
5 25 15.89±1.66 15.20-16.57
6 18 16.81±0.53 16.54-17.08
n: Number of subjects in each group (Sample size=136), SD: Standard deviation, 
CI: Confidence interval, CVM: Cervical vertebral maturation
Table 2: Age of the subjects in the different groups according to 
pubertal growth phase
Pubertal growth phase n Age (year)
Mean±SD 95% CI
Prepeak 41 10.87±1.15 10.51-11.23
Peak 52 13.36±2.23 12.74-13.99
Postpeak 43 16.27±1.38 15.85-16.70
n: Number of subjects in each group (Sample size=136) , SD: Standard 
deviation, CI: Confidence interval
Table 3: Level of salivary BALP in the different groups according 
to pubertal growth phase
Pubertal growth 
phase
n Salivary BALP (pg/ml) p
Mean±SD 95% CI
Prepeak 41 931.90±643.14 728.90-1134.90 0.312
Peak 52 782.28±451.10 656.69-907.87
Postpeak 43 777.58±499.52 623.84-931.31
n: Number of subjects in each group (Sample size=136), SD: Standard deviation, 
CI: Confidence interval, BALP: Bone-specific alkaline phosphatase
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with pubertal growth phase. It was also found that the association 
between salivary BALP and pubertal growth phase was not significant 
(p=0.312).
DISCUSSION
This study investigated the possible association between salivary BALP 
levels and pubertal growth phase. To date, there has been no study 
investigated the salivary BALP in relation to pubertal growth phase 
that was assessed with CVM method. One of the main reasons for the 
application of the method was that the analysis of CVM was performed 
on the lateral cephalogram, a type of radiographic used routinely in 
orthodontic examination.
When mean chronologic age of each CVM stage of this study were 
compared with Baccetti’s [5], the result showed that the Indonesian 
children reached each developmental stage later than white children. 
This result was in agreement with the previous by Soegiharto 
et al. [22].
The relation of GCF and salivary ALP total activity to growth phases 
had been studied. The authors found the highest concentration at 
peak pubertal growth phase and lower at others (pre- and post-peak) 
pubertal growth phase [1,23]. They concluded that ALP total activity in 
GCF and salivary could be used as adjunct methods in identification of 
pubertal growth phase. In human, however, tissue non-specific (liver, 
bone, and kidney), intestinal, and placental ALP isoforms had been 
identified. These sources could contribute to total ALP activity, where 
interpretation of the result will become even more difficult without 
fractionation of these ALP isoforms. Although separating the intestinal 
and placental ALPs was relatively easy, it was much more difficult to 
distinguish between BALP and liver ALP because these two isoforms 
were the products of a single gene and differ only with respect to 
posttranslational glycosylation [9]. For that reason, we measured the 
level of salivary BALP by using ELISA which has lower cross-reactivity 
with the other forms of ALP. We found that the mean level of salivary 
BALP decreased with pubertal growth phase and no significant 
differences were found between the groups. A potential cause related to 
this result was perhaps non-serum sources of BALP that can detectable 
in GCF from diseased periodontal sites and local bone remodeling 
processes [24,25].
Saliva has a wide spectrum of proteins/peptides, nucleic acids, 
electrolytes, and hormones that originate from multiple local and 
systemic sources. However, its use as a diagnostic fluid has been 
hindered, mainly because of our lack of understanding of the 
biomolecules present in saliva, combined with the lack of high-
sensitivity detection systems. As a diagnostic medium, saliva has 
disadvantages such as the fact that it would not always reliably reflect 
the concentrations of these molecules in serum. Salivary composition 
can also be influenced by the method of collection and the degree of 
stimulation of salivary flow [26].
CONCLUSION
This study did not find differences of salivary BALP level during 
the pubertal growth phases in Indonesian children. As a matter of 
fact, the use of salivary BALP as a biomarker for pubertal growth 
prediction was questionable. There is a need to construct further 
study exclusively for salivary BALP. Moreover, to explore other 
salivary biomarker indicating pubertal growth spurt is also becoming 
more important. To date, the radiographic methods such as CVM may 
be considered as the most preferred method for pubertal growth 
prediction in orthodontics.
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